Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

8.5K

[Non systemic forms of juvenile idiopathic arthristis]

Arthur Felix1, Cécile Dumaine2, Ulrich Meinzer2

  • 1Centre de référence des maladies rhumatologiques inflammatoires, des maladies auto-immunes et interféronopathies systémiques de l'enfant (RAISE), service de pédiatrie générale maladies infectieuses et médecine interne pédiatrique, CHU Robert-Debré, AP-HP, Université de Paris Cité, Paris, France. Centre de compétence RAISE Martinique, service de pédiatrie générale, CHU de la Martinique, Fort-de-France, France.

La Revue Du Praticien
|June 23, 2025
PubMed

Insights

Juvenile idiopathic arthritis (JIA) encompasses various forms classified by clinical and biological criteria. Early diagnosis and multidisciplinary management, including biotherapies for severe cases, lead to a generally good prognosis in children.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Medicine

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children under 16.
  • Accurate classification of JIA subtypes is crucial for effective management.
  • JIA diagnosis requires excluding other potential causes of arthritis.

Purpose of the Study:

  • To provide an overview of non-systemic JIA subtypes.
  • To detail the clinical and biological characteristics of JIA.
  • To outline the first-line management strategies for pediatric JIA.

Main Methods:

  • International classification criteria for JIA subtypes.
  • Clinical and biological assessment of pediatric patients.
  • Review of current management algorithms and therapeutic options.

Main Results:

  • JIA is classified into systemic, oligoarticular, polyarticular (RF+/-), enthesitis-related, and psoriatic arthritis.
  • Specific pediatric presentations and age-related particularities exist for JIA forms.
  • Multidisciplinary care coordinated by pediatric rheumatologists is standard.

Conclusions:

  • The prognosis for JIA has significantly improved due to advanced management and biotherapies.
  • Early recognition and appropriate treatment are key to favorable outcomes in JIA.
  • This overview aids in understanding JIA diagnosis and management in children.

Keywords:
Arthritis, Juvenile

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

377
A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model11:03

A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model

Published on: October 30, 2019

8.4K

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
683
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
71
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
586
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
53
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
36